Curevo Vaccine
Biotechnology Research • 
Bothell, Washington, United States • 21-50 Employees
Company overview
| Headquarters | 21540 30th Dr SE, Suite 260, Bothell, Washington 98021, US |
| Phone number | +12064925722 |
| Website | |
| NAICS | 541714 |
| Keywords | Clinical Trials, Drug Discovery, Public Health, Drug Development, Infectious Disease, Vaccines, Immunology, Adjuvants |
| Founded | 2017 |
| Employees | 21-50 |
| Socials |
Key Contacts at Curevo Vaccine
David Skibinski
Director, Immunology
George Simeon
Ceo
Mario Barro
Member Board Of Directors At Curevo
Adam Mazzo
Associate Director Of Quality Cmc
Shail Shah
Senior Director Of Regulatory Affairs
Kristi Stetzler
Human Resources Director
Hyang Moon
Director, Translational Research & Development
Haijing Qin
Director, Biostatistics
Jennifer Ortiz Torres
Director, Clinical Quality
Lisa Shelton
Senior Director Clinical Development
Curevo Vaccine Email Formats
Curevo Vaccine uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@curevovaccine.com), used 63.3% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@curevovaccine.com | 63.3% |
{first name}.{last name} | john.doe@curevovaccine.com | 36.7% |
About Curevo Vaccine
Curevo Vaccine is a clinical-stage developer of vaccines for varicella and herpes zoster. Amezosvatein (CRV-101) is an adjuvanted subunit (non-mRNA) vaccine designed to prevent herpes zoster, commonly known as shingles. Our goal with a new herpes zoster vaccine is to improve the patient experience and, ultimately, overall vaccination rates, by developing amezosvatein as a vaccine with non-inferior efficacy combined with clinically-meaningful improvements in reactogenicity when compared to Shingrix.
Curevo Vaccine revenue & valuation
| Annual revenue | $1,800,000 |
| Revenue per employee | $42,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $5,800,000 |
| Total funding | $136,000,000 |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Curevo Vaccine has 19 employees across 8 departments.
Departments
Number of employees
Funding Data
Explore Curevo Vaccine's funding history, including investment rounds, total capital raised, and key backers.
Curevo Vaccine Tech Stack
Discover the technologies and tools that power Curevo Vaccine's digital infrastructure, from frameworks to analytics platforms.
WordPress plugins
JavaScript libraries
Page builders
Analytics
JavaScript libraries
Font scripts
JavaScript libraries
Miscellaneous
Security
Programming languages
Blogs
Analytics
India
United Kingdom
Denmark
Frequently asked questions
4.8
40,000 users
